PTX3 and clear cell renal carcinoma: Data from the cancer genome atlas (TCGA) clear cell renal cell carcinoma patient cohort (KIRC), confirmed our findings showing a reduced survival in patients with high expression levels of PTX3 (Supplementary Figure 1).